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Abstract
In 2011, a large outbreak of infections caused by Shiga toxin-producing Escherichia coli (STEC) O104:H4 occurred in Germany. This
exceptionally virulent strain combined virulence factors of enteroaggregative E. coli (EAggEC) and STEC. After the outbreak only a few
sporadic cases of infection with this rare serotype were reported, most of which were related to travel to the Middle East or North Africa.
Here we describe two cases of enteroaggregative STEC (Agg-STEC) O104:H4 infection that occurred in Belgium in 2012 and 2013
respectively. In both cases travel in a Mediterranean country preceded the infection. The ﬁrst strain was isolated from the stool of a
42-year-old woman presenting bloody diarrhoea, who had travelled to Tunisia the week before. The second case involves a 14-year-old girl
who, upon her return from Turkey to Belgium, suffered from an episode of bloody diarrhoea and haemolytic uraemic syndrome. Extended
typing of the isolates with pulsed ﬁeld gel electrophoresis revealed that the strains were closely related, though not exactly the same as the
2011 outbreak strain. This report supports the previously made hypothesis that Agg-STEC has a human reservoir and might be imported by
travellers coming from an area where the pathogen is endemic. Furthermore, it emphasizes the concern that these bacteria may cause
future outbreaks as evenly virulent O104:H4 isolates seem to be widespread.
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Introduction
O157:H7 is the most common serotype in Shiga toxin- or
Vero(cyto)toxin-producing Escherichia coli (STEC/VTEC). A
key property of these strains is the production of “Attaching
and Effacing” (AE) lesions. STEC of different serotypes can
cause severe disease in humans, including haemorrhagic
colitis and haemolytic uraemic syndrome (HUS). For this
reason, a widely used acronym for these E. coli strains is
‘EHEC’ (enterohaemorrhagic E. coli). As there is no agree-
ment on the deﬁnition of enterohaemorrhagic strains, the
acronym ‘AE-STEC’ will be used throughout this paper to
refer to Shiga toxin- and AE-lesion-producing E. coli strains.
AE-STEC O157:H7 have the highest incidence and are the
most frequently involved in outbreaks (seropathotype A).
AE-STEC of serotypes O26:H11, O103:H2, O111:H-, O121:
H19 and O145:H- are also involved in severe human disease
and outbreaks, though less frequently (seropathotype B) [1].
In 2010, 40.7% of all reported STEC serogroups in Europe
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were O157. O26 was the most commonly reported
non-O157 serogroup (11%) [2].
From May to July 2011, a large outbreak of STEC infections
with a serotype that was reported only very rarely before,
O104:H4, occurred in Germany. This outbreak differed from
previous STEC outbreaks by its sheer size, the large percent-
age of patients with HUS and the high proportion of adults,
mainly women. This exceptionally virulent strain combined
virulence factors of enteroaggregative E. coli (EAggEC) and
STEC making it a mixed enteroaggregative and Shiga
toxin-producing E. coli (designated here as ‘Agg-STEC’) [1,3].
At the same time, a smaller outbreak of Agg-STEC O104:H4
took place in France. Comparison of the back tracing
information from the French and German outbreaks led to
the conclusion that fenugreek seeds imported from Egypt
were the most likely source of infection although the outbreak
strain could not be isolated from the seeds [4].
After the 2011 outbreak, only a few sporadic cases of
Agg-STEC of serotype O104:H4 were reported. In this paper,
we describe two imported cases of Agg-STEC O104:H4
infection that occurred in Belgium after the 2011 outbreak and
compare their phenotypic and genetic proﬁles with the
German outbreak strain recovered from a Luxembourg
resident who had travelled to the Hamburg area.
Case Descriptions
The ﬁrst case is a 42-year-old woman who presented on the
ﬁrst day of September 2012 to the emergency department of
the Universitair Ziekenhuis Brussel (Belgium) with complaints
of heavy abdominal cramps, nausea and watery diarrhoea. She
mentioned the presence of blood in the faeces. She had
returned 3 days before from a 1-week journey in Tunisia
where diarrhoea started in the morning, just before leaving.
She was not aware of other cases. A blood analysis was
normal, without signs of HUS (creatinine 0.62 mg/dL, haemo-
globin 13.4 g/dL, platelets 393 000/mm³). At physical exami-
nation only discrete signs of dehydration were present. She
was discharged with dietetic advice and a prescription of
EnterolTM (Saccharomyces boulardii) and domperidone. She did
not consult anymore, as she recovered uneventfully.
The second case involves a 14-year-old girl who was referred
from the regional hospital AZ Vesalius to the Universitair
Ziekenhuis Leuven (Belgium) in the third week of July 2013
because of abdominal pain, bloody stools, fever and general
malaise for 4 days. Her blood examination revealed signs of
HUS (anaemia with low haemoglobin 11.3 g/dL, increased levels
of lactate dehydrogenase and bilirubin total 10.21 mg/dL and
thrombocytopenia with platelet count 27 000/mm³), with
presence of schistocytes in peripheral blood smear and
decreased kidney function (oliguria, creatinine 1.07 mg/L, urea
68 mg/dL). She was treated supportively with spontaneous
recovery of her kidney function. No dialysis was needed. The
patient had travelled to Turkey during the ﬁrst 2 weeks of July
where she developed watery diarrhoea that spontaneously
resolved after 5 days. Upon her return to Belgium she suffered
from a new episode of diarrhoea, this time with the presence of
blood in stools, and she developed HUS 6 days later.
The strains isolated from these patients were compared
with an isolate related to the German outbreak. A 51-year-old
woman residing in Luxembourg travelled for several days
during the second week of May 2011 in the Hamburg region in
Germany. Hamburg was the German state with the highest
incidence (10 cases per 100 000 population) of reported HUS
during the outbreak [3]. A few days after her return, she
developed diarrhoea, which gradually worsened until she
noticed blood in her faeces and consulted a physician who
prescribed a stool culture. The patient recovered without
developing HUS.
Methods and Results
In both Belgian cases a STEC O104:H4, referred to as EH2211
and EH2303, respectively, was recovered out of the stools by
using methods described elsewhere [5]. Slide agglutination was
performed with the K9 antiserum (Statens Serum Institut,
Copenhagen, Denmark), indicative of the O104 serogroup [6].
The full serotype was conﬁrmed by a positive PCR result
for O104 (wzxO104) and H4 (ﬂiCH4) [7]. Both strains grew
on sorbitol–MacConkey agar with ceﬁxime and tellurite
(SMAC-CT), fermented sorbitol and were b-glucuronidase
positive. By contrast with EH2211, EH2303 did not ferment
lactose. A PCR was positive for aaiC and aggR genes [8], but
negative for the STEC virulence genes intimin (eaeA) and
enterohaemolysin (hlyA) [9]. Both strains possessed the Shiga
toxin 2a (stx2a) subtype, as described by Scheutz et al. [10].
Disc diffusion susceptibility testing according to EUCAST
recommendations (or CLSI when no breakpoints were
available from the former) was performed using antibiotics
selected by the Programme for Food- and Waterborne
Diseases and Zoonoses (FWD) and revealed that strain
EH2211 had an intermediate susceptibility to nalidixic acid
and was resistant to ampicillin and trimethoprim. EH2303 on
the other hand was resistant to ampicillin, amoxicillin/clavul-
anic acid, cefazolin, cefuroxime, cefotaxime, ceftriaxone,
ceftazidime, cefepime, aztreonam, sulfonamides, trimethoprim
and nalidixic acid. No extended-spectrum b-lactamase (ESBL)
was detected for EH2211 according to CLSI screening
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and conﬁrmatory tests; but EH2303 tested ESBL positive,
further characterized by the National Reference Centre for
multiresistant Enterobacteriaceae as CTX-M-15; a TEM-1
b-lactamase was also present.
Pulsed-ﬁeld gel electrophoresis using XbaI was performed
using the PulseNet standard operating procedure [11] to
compare these two Agg-STEC O104:H4 strains with C110638,
an Agg-STEC O104:H4 from Luxembourg linked to the 2011
German outbreak, and EH1651, an unrelated STEC O104:H2
strain included in the study of Miko et al. [12] (Table 1).
Strain EH2303 clustered closest to the 2011 outbreak strain
with 91.9% similarity. Using a cut-off value of 80% similarity the
three O104:H4 strains could be divided in the same cluster A,
whereas strain EH1651 showed only 69.7% similarity and
formed a separate group B (Fig. 1).
Discussion
Although O104:H4 is a rare serotype in humans, a few
sporadic infections caused by E. coli O104:H4 took place
before 2011. STEC O104:H4 caused a case of HUS in South
Korea (2004), but this strain was not enteroaggregative [13].
EAggEC O104:H4 has been associated with human diarrhoea
in South Africa (2007, 2009 and 2010) and Canada (2010)
[14,15]. Agg-STEC O104:H4 have been isolated from patients
with HUS in Germany (2001), France (2009) and Italy (2009);
from two patients with bloody diarrhoea in the Republic of
Georgia (2009); from a patient with haemorrhagic colitis in
France (2004); and from patients in Norway (2006) and
Sweden (2010) [16–20]. After the German and French
outbreaks, cases of Agg-STEC occurred in France, Germany
and Denmark [21,22]. HUS caused by Agg-STEC other than
O104:H4 has been reported in France (1992), Japan (1999) and
Ireland (2012). The strains belonged to serotypes O111:H2,
O86:HNM and O111:H21, respectively [23–25] (Table 2).
Common characteristics of EH2211, EH2303 and the
German outbreak strain include: ability to grow on SMAC-CT
agar; positive PCR results for aaiC, aggR, stx2a, wzxO104 and
ﬂiCH4; negative PCR results for eaeA, hlyA and stx1; aggluti-
nation with K9 antiserum; fermentation of sorbitol and
production of b-glucuronidase. The outbreak strain and strain
EH2303 were both multiresistant and produced an ESBL
CTX-M-15 while EH2211 was susceptible to most tested
antibiotics [6,22,26]. A remarkable characteristic of strain
EH2303 is the fact that it did not ferment lactose. To the best
of our knowledge, this is the ﬁrst lactose-negative Agg-STEC
O104:H4 strain ever reported.
Strain EH2303 shows more similarity to the strain from
Luxembourg than EH2211 based on their pulsed ﬁeld gel
electrophoresis proﬁles. Closely related, but not identical,
pulsed ﬁeld gel electrophoresis XbaI patterns of E. coli O104:
H4 strains isolated before and after the German 2011
outbreak have already been described [12,21].
In the cases described in this paper, travel to Turkey and
Tunisia preceded the infection with Agg-STEC O104:H4,
suggesting that the infection was acquired in these countries.
Indeed, other sporadic cases of infection with E. coli O104:H4,
as well as an outbreak associated with travel to Turkey or
North Africa, have been reported in Europe. According to the
information reported to European Centre for Disease Pre-
vention and Control, four of the STEC O104 cases in the EU
Member States in the period 2004–2010 were travel-related;
the countries of origin of infection were Afghanistan, Egypt,
Tunisia and Turkey. One of those was of the serotype O104:
H4; a Finnish case with infection acquired in Egypt [26].
Infections of Agg-STEC O104 were noted in Italy (2009) and
Sweden (2010). As in the present case, they were linked to
travel to Tunisia [19,20]. In September 2011, an outbreak of
HUS due to Agg-STEC O104:H4 occurred among French
tourists returning from Turkey. Around that same period, two
patients from Germany and one from Denmark were
diagnosed with an Agg-STEC O104:H4 infection, also after
travel to Turkey [21]. Out of four sporadic isolates of E. coli
O104:H4 from children with HUS in France, one was
associated with recent travel to North Africa [22].
TABLE 1. Features of the strains analysed in this publication
Strain Country of isolation Year of isolation Travel related Serotype Stx-subtype
Virulence genes
ESBL Lactose
AE-STEC EAggEC
eaeA hlyA aaiC aggR
EH1651 Belgium 2008 Morocco O104:H2 Stx2b      +
C110638 Luxembourg 2011 Hamburg, Germany O104:H4 Stx2a   + + + +
EH2211 Belgium 2012 Tunisia O104:H4 Stx2a   + +  +
EH2303 Belgium 2013 Turkey O104:H4 Stx2a   + + + 
EH1651 is a historical O104 Shiga toxin-producing Escherichia coli (STEC) strain from our collection and was included in this study as a control; AE-STEC, ‘Attaching and
Effacing’-lesions- and Shiga toxin-producing E. coli; EAggEC, enteroaggregative E. coli; ESBL, extended-spectrum b-lactamase; Stx, Shiga toxin.
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Whereas AE-STEC is clearly a zoonosis, mainly related to
ruminants, no animal reservoir has been reported for
EAggEC nor Agg-STEC. Studies conducted in cattle in
Germany and France during the 2011 outbreak were not
able to detect the presence of the outbreak strain, indicating
that cattle are not the reservoir of Agg-STEC [27,28]. As no
other natural reservoir has been established, it has been
hypothesized Agg-STEC has a human reservoir and might be
imported into the European Union by travellers or migrants
coming from an area where the pathogen is endemic [29].
Without an animal reservoir, it is not expected that
Agg-STEC strains can be maintained in countries with high
standards of hygiene.
Comparative genomics of E. coli O104:H4 strains isolated
before, during and after the 2011 outbreak provided us with
better insight into the evolution of this serotype. Genomic
analysis of a number of post-outbreak O104:H4 strains has
shown that they are not derived from the 2011 outbreak but
share a recent common ancestor [22]. A nearly identical Shiga
toxin-carrying prophage was found in several of the historical
O104:H4 strains, which suggests that the prophage was
transferred into the O104:H4 population at least a decade
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FIG. 1. Pulsed-ﬁeld gel electrophoresis XbaI proﬁles of EH1651 (O104:H2), EH2211 (O104:H4), EH2303 (O104:H4) and C110638 (O104:H4). The
dendrogram was generated with the BIONUMERICS 6.5 software (Applied Maths, Sint-Martens-Latem, Belgium) using Dice coefﬁcients and the
unweighted pair group method with arithmetic mean. Using a cut-off value of 80% similarity two clusters, A and B, can be detected.
TABLE 2. Overview of enteroaggregative Shiga toxin-producing Escherichia coli infections described in literature
References
Year of
isolation
Country of
isolation Serotype
Source of
infection
Sporadic or outbreak
related Imported? Disease Stx ESBL
Lac
tose
[23,30] 1992 France O111:H2 Probably person to
person transmission;
no food or drinks
found
Outbreak (n = ?;
8 strains with Agg
phenotype)
NR D, BD, HUS Stx2 NR NR
[24] 1999 Japan O86:HNM NR Sporadic NR HUS,
encephalopathy
Stx2 NR NR
[16,31] 2001 Germany O104:H4 NR Sporadic NR HC, HUS Stx2 NR NR
[18] 2004 France O104:H4 NR Sporadic NR HC Stx2  NR
[16] 2006 Norway O104:H4 NR Sporadic NR D Stx2 NR NR
[18] 2009 France O104:H4 NR Sporadic NR HUS Stx2  NR
[19] 2009 Italy O104:H4 Probably person
to person
transmission
Sporadic Tunisia, travel BD, HUS Stx2  NR
[6,32] 2009 Republic
of Georgia
O104:H4 NR Outbreak (n = ?;
2 strains with Agg
phenotype)
NR BD Stx2a  +
[20] 2010 Sweden O104:H4 NR Sporadic Tunisia, travel NR Stx2  NR
[3,6] 2011 Germany O104:H4 Probably seeds,
grown to fenugreek
sprouts
Outbreak (n = 3816) Probably Egyptian
seeds
D, BD, HUS Stx2 + +
[3,33] 2011 France O104:H4 Probably seeds,
grown to fenugreek
sprouts
Outbreak (n = 24) Probably Egyptian
seeds
D, BD, HUS Stx2 + +
[22] 2011 France O104:H4 NR Sporadic NR HUS Stx2  NR
[22] 2011 France O104:H4 NR Sporadic NR HUS Stx2  NR
[22] 2011 France O104:H4 NR Sporadic Turkey, travel HUS Stx2  NR
[22] 2011 France O104:H4 NR Sporadic NR HUS Stx2  NR
[22] 2011 France O104:H4 NR Sporadic North Africa,
travel
HUS Stx2  NR
[21] 2011 Germany O104:H4 NR Sporadic Turkey, travel BD Stx2  NR
[21] 2011 Germany O104:H4 NR Sporadic Turkey, travel BD Stx2  NR
[21] 2011 Denmark O104:H4 NR Sporadic Turkey, travel D Stx2  NR
[21] 2011 France O104:H4 NR Outbreak (n = 8) Turkey, travel D, BD, HUS Stx2  NR
[25] 2012 Ireland O111:H21 NR Outbreak, household
(n = 3)
 D, HUS Stx2c  NR
This report 2012 Belgium O104:H4 NR Sporadic Tunisia, travel BD Stx2a  +
This report 2013 Belgium O104:H4 NR Sporadic Turkey, travel HUS Stx2a + 
NR, not reported; , negative; +, positive; D, diarrhoea; BD, bloody diarrhoea; HC, haemorrhagic colitis; HUS, haemolytic uraemic syndrome; ESBL, extended-spectrum
b-lactamase; Stx, Shiga toxin.
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ago. On the other hand, acquisition of the antibiotic resistance
plasmid pESBL and gene cassettes for antibiotic resistances
seems to be one of the most recent events in the evolutionary
history [20,22]. The two cases reported here had differing
antibiotic resistance proﬁles. Strain EH2211 was susceptible to
most antibiotics, whereas EH2303 was multiresistant, as was
the 2011 outbreak strain, and carried a CTX-M-15 type ESBL.
In conclusion, the cases described here support the
previously expressed concern that these bacteria may cause
future severe outbreaks as evenly virulent, though not exactly
the same, O104:H4 isolates seem to be widespread.
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